Search Results

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India.

Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from His laboratory is currently located at the Institute Cochin – Inserm (Paris, France).

oncology research led me to pursue a BSc in Biology & Economics from Carleton University, and an MSc in Biotechnology In my role at Orion Biotechnology, I work at the intersection of science and business, which includes Caron currently holds multiple scientific advisory roles in academia, industry and the National Institutes Undergraduate Research Program and is working to build relationships with key stakeholders through institutional

Deputy Director, and Better Medicines Theme Leader of the Neuromedicines Discovery Centre at the Monash Institute Prior to these roles this he was Head of Pharmacology at Heptares Therapeutics Ltd., a UK-based biotechnology

Oliver Hartley Oliver Hartley is VP for Drug Discovery at Orion Biotechnology . Oliver Hartley on the web LinkedIn Orion Biotechnology Dr.

University of Montreal in Canada before training at Rockefeller University in New York and the National Institutes Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health. She received her undergraduate degree in Biotechnology from KIIT University in India. GPCR About Cam Sinh Lu Cam Sinh Lu is a PhD student at Monash Institute of Pharmaceutical Sciences, Monash

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes Caroline Gorvin is a Wellcome Trust & Royal Society Sir Henry Dale Fellow at the Institute of Metabolism

in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin Lohse at the Institute order to focus my research on class Frizzled GPCR s in the lab of Gunnar Schulte at the Karolinska Institute Hannes Schihada on the web Karolinska Institutet Twitter Adher´n Rise LinkedIn Dr.

Arun Shukla's lab at the Indian Institute of Technology, Kanpur attacks this question from multiple angles He completed his PhD at the Max Planck Institute of Biophysics in Frankfurt and postdoctoral training Arun Shukla from the Indian Institute of Technology in Kanpur, India. He earned his master's degree in biotechnology from Jawaharlal Nehru University in India and it was during Arun Shukla on the web Indian Institute of Technology Dr.

following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology

Avanzados del IPN (in English: Center for Research and Advanced Studies of the National Polytechnic Institute Instituto Politécnico Nacional no 2508 Mexico City, C.P. 07360 Room: Auditorium Arturo Rosenblueth *Have

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Elodie Dupuis earned her Master’s degree in biology and biotechnology engineering from the University She has been leading collaborative projects with public research institutes and pharmaceutical companies , most notably the joint Revvity/Institute of Functional Genomics team, EIDOS. Mathis holds a biotechnology engineering degree from the National School of Biomolecule Technology of

As co-founder and CEO of Keltic Pharma Therapeutics, he leads a biotechnology company developing a novel

Her work is currently funded by Biotechnology and Biological Sciences Research Council (BBSRC), Diabetes

Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics Ltd , a biotechnology

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology Additionally, they explored the unique culture and structure of their Institute, highlighting its translational Lastly, they discussed the growth and development of the Monash Institute of Pharmaceutical Sciences, research, highlighting the unique opportunities presented by their location and partnerships with other institutions

Sexton is also a co-founder of the San Francisco-based biotechnology company Septerna Inc . Dr.

based in South Korea, has recently been named President of GPCR Therapeutics, USA, a newly incorporated Biotechnology

Gunnar Schulte of Karolinska Institute makes the case that frizzled receptors are GPCRs — through G-protein Gunnar Schulte's lab at Karolinska Institute has spent years assembling the evidence on the other side Guest Gunnar Schulte is a professor at the Department of Physiology and Pharmacology at Karolinska Institute pivoted to frizzled receptors during a postdoctoral fellowship with Ernest Arenas, staying at the same institution As a postdoc, he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology; 2003

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute From 2013-2018, he was also a Professor at the Skolkovo Institute of Science and Technology (Skoltech Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched at the Institute 1992 from the Russian Academy of Medical Sciences and an M.D. in 1988 from the Second Moscow Medical Institute

and chair of the Department of Computational and Quantitative Medicine (DCQM) at the Beckman Research Institute Vaidehi received her Ph.D. in quantum chemistry from the Indian Institute of Technology in India, where became the director of biomolecular simulations at the Materials and Process Simulation Center, Beckman Institute Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair

He completed postdoctoral training at the Weizmann Institute. In 1983, he joined the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health, in Bethesda, MD.

His scientific training included a PhD at the International Center for Genetic Engineering and Biotechnology

independent research positions from 2001 at University of Sydney (opioids and sensory neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney).

He then earned his Ph.D. in physical chemistry from the Massachusetts Institute of Technology, training training in the laboratories of Professors Raymond Stevens and Kurt Wüthrich at The Scripps Research Institute

Antonella Di Pizio — who leads the computational pharmacology group at the Leibniz Institute for Food Biology at the Technical University of Munich, where she was the first group leader appointed to the institute's Di Pizio arrived in October 2018, she founded the first computational group in an institute whose original Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology Antonella Di Pizio on the web Leibniz-Institute for Food Systems Biology at the Technical University

Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Unit at the National Institutes of Health – National Institute on Aging at the Johns Hopkins University Medical Center.